Med Biogene(TSE:MBI.H)
CA$0.020.00 (0.00%)
TSE:MBI.H
Med Biogene financials statements
CA$0.02
At close:0.00 (0.00%)
Med Biogene (MBI.H) Financial Statements
4 Followers
Med Biogene Financial Overview
Med Biogene's market cap is currently $258.87K. The company's EPS TTM is ―; its P/E ratio is -4.05; Med Biogene has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ― | ― | ― | ― | ― |
| Gross Profit | ― | ― | ― | ― | ― |
| Operating Income | $ -58.11K | $ -63.06K | $ -59.96K | $ -54.54K | $ -63.48K |
| EBITDA | $ -58.11K | $ -63.06K | $ -59.96K | $ -54.54K | $ -63.48K |
| Net Income | $ -58.11K | $ -63.06K | $ -59.96K | $ -54.54K | $ -63.48K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ― | ― | ― | ― | ― |
| Total Assets | $ 2.31K | $ 3.00K | $ 10.79K | $ 81.83K | $ 13.15K |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -713.00 | $ -407.00 | $ -9.19K | $ -79.24K | $ -10.96K |
| Total Liabilities | $ 129.30K | $ 69.23K | $ 92.01K | $ 178.16K | $ 50.42K |
| Stockholders' Equity | ― | ― | ― | ― | ― |
| Cash Flow | |||||
| Free Cash Flow | ― | $ -8.32K | $ -145.12K | $ 72.80K | $ -151.46K |
| Operating Cash Flow | ― | ― | ― | ― | ― |
| Investing Cash Flow | ― | ― | ― | ― | ― |
| Financing Cash Flow | ― | ― | ― | ― | ― |
Currency in USD

